{"DataElement":{"publicId":"3279223","version":"1","preferredName":"Smoking Cessation Medication Use Type","preferredDefinition":"Text to describe the kind of medication used to help stop smoking.","longName":"3276640v1.0:3276672v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3276640","version":"1","preferredName":"Smoking Cessation Medication Use","preferredDefinition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe._A stopping.__A drug or medicine that treats or prevents or alleviates the symptoms of disease._Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"2435430v1.0:3276643v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2435430","version":"1","preferredName":"Smoking","preferredDefinition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.","longName":"C17934","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tobacco Smoking","conceptCode":"C17934","definition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06F596AE-CCB2-4492-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-12-08","modifiedBy":"ONEDATA","dateModified":"2005-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3276643","version":"1","preferredName":"Cessation Medication Use","preferredDefinition":"A stopping.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.:Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"C61497:C459:C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cessation","conceptCode":"C61497","definition":"A stopping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9467-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008566","version":"1","preferredName":"Behavior","preferredDefinition":"Observations and activities relating to behavior, such as smoking and ETOH use.\r\n","longName":"BEHAVIOR","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B78145CC-5DBF-209B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-02-25","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-25","modifiedBy":"REEVESD","dateModified":"2004-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9445-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by S.Shakour. mc 9/21/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3276672","version":"1","preferredName":"Smoking Cessation Medication Type","preferredDefinition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe._A stopping._biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products._Type; a subdivision of a particular kind of thing.","longName":"3276672v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not sure","valueDescription":"Uncertain","ValueMeaning":{"publicId":"2749725","version":"1","preferredName":"Uncertain","longName":"2749725v1.00","preferredDefinition":"Not established beyond doubt; still undecided or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uncertain","conceptCode":"C47944","definition":"Not established beyond doubt; still undecided or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D3ED582-F0E6-7509-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-05-15","modifiedBy":"MMADDINENI","dateModified":"2022-09-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-9581-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Chantix","valueDescription":"Varenicline Tartrate","ValueMeaning":{"publicId":"3276674","version":"1","preferredName":"Varenicline Tartrate","longName":"3276674","preferredDefinition":"A drug used to help people stop smoking by acting the same way nicotine acts in the brain. It is a type of nicotine receptor partial agonist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Varenicline Tartrate","conceptCode":"C61998","definition":"A drug used to help people stop smoking by acting the same way nicotine acts in the brain. It is a type of nicotine receptor partial agonist.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-958F-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-95A8-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Zyban or buproprion","valueDescription":"Bupropion Hydrochloride","ValueMeaning":{"publicId":"3276676","version":"1","preferredName":"Bupropion Hydrochloride","longName":"3276676","preferredDefinition":"The hydrochloride salt of an aminoketone antidepressant. The molecular mechanism of the antidepressant effect of bupropion is unknown.  This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bupropion Hydrochloride","conceptCode":"C1317","definition":"The hydrochloride salt of the aminoketone bupropion, with antidepressant activity and for potential use in promoting smoking cessation and improving sexual desire. Bupropion is a weak blocker of the neuronal uptake of serotonin, dopamine and norepinephrine and is a central nicotinic acetylcholine receptor antagonist.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-95B5-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-95CE-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Nicotine lozenge","valueDescription":"Nicotine Lozenge","ValueMeaning":{"publicId":"3276678","version":"1","preferredName":"Nicotine Lozenge","longName":"3276678","preferredDefinition":"A lozenge preparation containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the lozenge, nicotine is released and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Lozenge","conceptCode":"C90531","definition":"A lozenge preparation containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the lozenge, nicotine is released and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-95DB-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-95F4-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Nicotine nasal spray","valueDescription":"Nicotine Nasal Spray","ValueMeaning":{"publicId":"3276680","version":"1","preferredName":"Nicotine Nasal Spray","longName":"3276680","preferredDefinition":"A nasal spray composed of an aqueous solution containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the spray into the nostrils, nicotine is taken up from the nasal mucosa into the bloodstream. Although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Nasal Spray","conceptCode":"C16162","definition":"A nasal spray composed of an aqueous solution containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the spray into the nostrils, nicotine is taken up from the nasal mucosa into the bloodstream. Although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9601-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-961A-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Nicotine inhaler","valueDescription":"Nicotine Inhaler","ValueMeaning":{"publicId":"3276682","version":"1","preferredName":"Nicotine Inhaler","longName":"3276682","preferredDefinition":"A device consisting of a mouthpiece and a thin, plastic cartridge that contains nicotine plug and delivers nicotine in a vapor that is absorbed in the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Inhaler","conceptCode":"C19977","definition":"A device consisting of a mouthpiece and a thin, plastic cartridge that contains nicotine plug and delivers nicotine in a vapor that is absorbed in the mouth.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9627-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-9640-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Nicotine gum","valueDescription":"Nicotine Gum","ValueMeaning":{"publicId":"3276683","version":"1","preferredName":"Nicotine Gum","longName":"3276683","preferredDefinition":"A chewing gum containing nicotine used as a substitute for the active ingredient in tobacco. Nicotine chewing gum reduces the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Gum","conceptCode":"C15663","definition":"A chewing gum containing nicotine used as a substitute for the active ingredient in tobacco. Nicotine chewing gum reduces the withdrawal symptoms associated with smoking cessation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-964C-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-9665-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Nicotine skin patch","valueDescription":"Nicotine Patch","ValueMeaning":{"publicId":"2578320","version":"1","preferredName":"Nicotine Patch","longName":"2578320","preferredDefinition":"A transepidermal patch designed to deliver nicotine, the addictive substance contained in cigarettes, directly through the skin and into the blood stream. Used for cessation of smoking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Patch","conceptCode":"C17955","definition":"A transdermal patch containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the patch, nicotine is slowly released into the bloodstream and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FEFD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-15","modifiedBy":"ONEDATA","dateModified":"2006-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACFBB39A-9679-633A-E040-BB89AD436C25","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008566","version":"1","preferredName":"Behavior","preferredDefinition":"Observations and activities relating to behavior, such as smoking and ETOH use.\r\n","longName":"BEHAVIOR","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B78145CC-5DBF-209B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-02-25","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-25","modifiedBy":"REEVESD","dateModified":"2004-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3276671","version":"1","preferredName":"Smoking Cessation Medication Type","preferredDefinition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.:A stopping.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.:Type; a subdivision of a particular kind of thing.","longName":"C17934:C61497:C459:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tobacco Smoking","conceptCode":"C17934","definition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cessation","conceptCode":"C61497","definition":"A stopping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9550-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9561-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"HARTLEYG","dateModified":"2016-02-09","changeDescription":"Released per approval by S.Shakour. mc 9/21/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3259219","version":"1","longName":"University of Michigan","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3259220","version":"1","longName":"Health Survey ","context":"NCIP"},{"publicId":"3259229","version":"1","longName":"Cancer Related Risks ","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which stop-smoking medication","type":"Preferred Question Text","description":"Which stop-smoking medications have you used?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD0280C6-B2FD-464E-E040-BB89AD437EDB","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"COOPERM","dateModified":"2011-09-26","changeDescription":"Released per approval by S.Shakour. mc 9/21/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}